Hong Kong stock market anomaly | China Antibody-B (03681.HK) rises by more than 20% again, the company's rights issue raised a net amount of 369 million Hong Kong dollars, intended for use in clinical trials of SM03 and other projects.
According to the Securities Times app, China Anti-B (03681.HK) surged over 20% again. As of the time of publication, it rose by 19.39%, reaching 314 million Hong Kong dollars, with a trading volume of 115 million Hong Kong dollars.
Latest
